Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting

Scholarly Works

• Paulus, J.; Sewald, N. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment. Journal of peptide science : an official publication of the European Peptide Society 2024, 30, e3561. doi:10.1002/psc.3561
• Zambra, M.; Ranđelović, I.; Talarico, F.; Borbély, A.; Svajda, L.; Tóvári, J.; Mező, G.; Bodero, L.; Colombo, S.; Arrigoni, F.; Fasola, E.; Gazzola, S.; Piarulli, U. Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker. Frontiers in pharmacology 2023, 14, 1215694. doi:10.3389/fphar.2023.1215694
• Davis, R. A.; Ganguly, T.; Harris, R.; Hausner, S. H.; Kovacs, L.; Sutcliffe, J. L. Synthesis and Evaluation of a Monomethyl Auristatin E─Integrin αvβ6 Binding Peptide-Drug Conjugate for Tumor Targeted Drug Delivery. Journal of medicinal chemistry 2023, 66, 9842–9852. doi:10.1021/acs.jmedchem.3c00631
• Cossu, J.; Thoreau, F.; Boturyn, D. Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues. Pharmaceutics 2023, 15, 525. doi:10.3390/pharmaceutics15020525
• Paulus, J.; Nachtigall, B.; Meyer, P.; Sewald, N. RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index. Chemistry (Weinheim an der Bergstrasse, Germany) 2023, 29, e202203476. doi:10.1002/chem.202203476
• Gomari, M. M.; Abkhiz, S.; Pour, T. G.; Lotfi, E.; Rostami, N.; Monfared, F. N.; Ghobari, B.; Mosavi, M.; Alipour, B.; Dokholyan, N. V. Peptidomimetics in cancer targeting. Molecular medicine (Cambridge, Mass.) 2022, 28, 146. doi:10.1186/s10020-022-00577-3
• Zhu, W.; Wang, Y.; Lv, L.; Wang, H.; Shi, W.; Liu, Z.; Yang, W.; Zhu, J.; Lu, H. SHTXTHHly, an extracellular secretion platform for the preparation of bioactive peptides and proteins in Escherichia coli. Microbial cell factories 2022, 21, 128. doi:10.1186/s12934-022-01856-8
• Todorovic, M.; Rivollier, P.; Wong, A. A. W. L.; Wang, Z.; Pryyma, A.; Nguyen, T. T.; Newell, K. C.; Froelich, J.; Perrin, D. M. Rationally Designed Amanitins Achieve Enhanced Cytotoxicity. Journal of medicinal chemistry 2022, 65, 10357–10376. doi:10.1021/acs.jmedchem.1c02226
• Zuppone, S.; Assalini, C.; Minici, C.; Botrugno, O. A.; Curnis, F.; Degano, M.; Corti, A.; Montorsi, F.; Salonia, A.; Vago, R. A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer. Frontiers in oncology 2022, 12, 846958. doi:10.3389/fonc.2022.846958
• Pryyma, A.; Matinkhoo, K.; Bu, Y. J.; Merkens, H.; Zhang, Z.; Bénard, F.; Perrin, D. M. Synthesis and preliminary evaluation of octreotate conjugates of bioactive synthetic amatoxins for targeting somatostatin receptor (sstr2) expressing cells. RSC chemical biology 2022, 3, 69–78. doi:10.1039/d1cb00036e
• Vakhrushev, A. V.; Demin, A. M.; Krasnov, V. P. Synthesis of fluorescent GRGD peptide derivatives. In AIP Conference Proceedings, AIP Publishing, 2022; pp 20083 ff. doi:10.1063/5.0069274
• Pryyma, A.; Matinkhoo, K.; Bu, Y. J.; Merkens, H.; Zhang, Z.; Benard, F.; Perrin, D. M.
• Matinkhoo, K.; Wong, A. A. W. L.; Hambira, C. M.; Kato, B.; Wei, C.; Müller, C.; Hechler, T.; Braun, A.; Gallo, F.; Pahl, A.; Perrin, D. M. Design, Synthesis, and Biochemical Evaluation of Alpha-Amanitin Derivatives Containing Analogs of the trans-Hydroxyproline Residue for Potential Use in Antibody-Drug Conjugates. Chemistry (Weinheim an der Bergstrasse, Germany) 2021, 27, 10282–10292. doi:10.1002/chem.202101373
• Balachandra, C.; Padhi, D.; Govindaraju, T. Cyclic Dipeptide: A Privileged Molecular Scaffold to Derive Structural Diversity and Functional Utility. ChemMedChem 2021, 16, 2558–2587. doi:10.1002/cmdc.202100149
• Bodero, L.; Parente, S.; Arrigoni, F.; Klimpel, A.; Neundorf, I.; Gazzola, S.; Piarulli, U. Synthesis and Biological Evaluation of an isoDGR-Paclitaxel Conjugate Containing a Cell-Penetrating Peptide to Promote Cellular Uptake. European Journal of Organic Chemistry 2021, 2021, 2383–2387. doi:10.1002/ejoc.202100241
• Battistini, L.; Bugatti, K.; Sartori, A.; Curti, C.; Zanardi, F. RGD Peptide-Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances. European Journal of Organic Chemistry 2021, 2021, 2506–2528. doi:10.1002/ejoc.202100240
• Gallo, F.; Korsak, B.; Müller, C.; Hechler, T.; Yanakieva, D.; Avrutina, O.; Kolmar, H.; Pahl, A. Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain. Journal of medicinal chemistry 2021, 64, 4117–4129. doi:10.1021/acs.jmedchem.1c00003
• Panzeri, S.; Arosio, D.; Gazzola, S.; Belvisi, L.; Civera, M.; Potenza, D.; Vasile, F.; Kemker, I.; Ertl, T.; Sewald, N.; Reiser, O.; Piarulli, U. Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-β-ACPC) Scaffolds. Molecules (Basel, Switzerland) 2020, 25, 5966–5980. doi:10.3390/molecules25245966
• Pryyma, A.; Matinkhoo, K.; Wong, A. A. W. L.; Perrin, D. M. Meeting key synthetic challenges in amanitin synthesis with a new cytotoxic analog: 5'-hydroxy-6'-deoxy-amanitin. Chemical science 2020, 11, 11927–11935. doi:10.1039/d0sc04150e
• Dordoni, F.; Scarpi, D.; Bianchini, F.; Contini, A.; Occhiato, E. G. Enantioselective Synthesis of cis and trans 4-Aminopipecolic Acids as γ-Amino Acids for the Construction of Cyclic RGD-Containing Peptidomimetics Antagonists of αVβ3 Integrin. European Journal of Organic Chemistry 2020, 2020, 4371–4383. doi:10.1002/ejoc.202000634

Explore citations to this article at